Literature DB >> 33823169

Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations.

Sandhya R Panch1, Brent Logan2, Jennifer A Sees3, Stephanie Bo-Subait3, Bipin Savani4, Nirali N Shah5, Jack W Hsu6, Galen Switzer7, Hillard M Lazarus8, Paolo Anderlini9, Peiman Hematti10, Dennis Confer3, Michael A Pulsipher11, Bronwen E Shaw12, David F Stroncek1.   

Abstract

Approximately 7% of unrelated hematopoietic stem cell donors are asked to donate stem cells a subsequent time to the same or a different recipient. Recent studies have shown that donation-related symptoms for second donations are similar to those for the first donation. Little is known about differences in stem cell mobilization and yields for subsequent peripheral blood stem cell (PBSC) and bone marrow (BM) collections. We hypothesized that CD34+ cell yields and total nucleated cell (TNC) concentrations for subsequent PBSC or BM donations are lower than those at the first donation. We also evaluated the factors influencing stem cell yields in healthy unrelated second-time donors. Data were gathered from the Center for International Blood and Marrow Transplant Research database on 513 PBSC and 43 BM donors who donated a second time between 2006 and 2017 through the National Marrow Donor Program. Among the second-time PBSC donors, we found significantly lower preapheresis peripheral blood CD34+ cell counts (68.6 × 106/L versus 73.9 × 106/L; P = .03), and collection yields (556 × 106 versus 608 × 106; P = .02) at the second donation compared to the first. This decrease at the subsequent donation was associated with a shorter interdonation interval, lower body mass index (BMI), and a lower total G-CSF dose. In most instances, suboptimal mobilizers at their first donation donated suboptimal numbers of stem cells at their subsequent donations. Among repeat BM donors, the TNC concentration was lower at the second donation. The small size of this group precluded additional analysis. Overall, when considering repeat donations, increasing the interdonation intervals and evaluating for BMI changes should be considered to optimize stem cell yields. Some of these parameters may be improved by increasing G-CSF dose in PBSC donors within permissible limits.
Copyright © 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Donors; G-CSF; Transplantation

Mesh:

Substances:

Year:  2021        PMID: 33823169      PMCID: PMC8217152          DOI: 10.1016/j.jtct.2021.03.008

Source DB:  PubMed          Journal:  Transplant Cell Ther        ISSN: 2666-6367


  30 in total

1.  Repeated peripheral stem cell mobilization in healthy donors: time-dependent changes in mobilization efficiency.

Authors:  A Tichelli; J Passweg; T Hoffmann; M Gregor; T Kühne; G Favre; A Wodnar-Filipowicz; A Gratwohl
Journal:  Br J Haematol       Date:  1999-07       Impact factor: 6.998

2.  Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections.

Authors:  P Anderlini; J Lauppe; D Przepiorka; D Seong; R Champlin; M Körbling
Journal:  Br J Haematol       Date:  1997-02       Impact factor: 6.998

Review 3.  In vivo dynamics of human hematopoietic stem cells: novel concepts and future directions.

Authors:  Serena Scala; Alessandro Aiuti
Journal:  Blood Adv       Date:  2019-06-25

4.  The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.

Authors:  Nicole L Prokopishyn; Brent R Logan; Deidre M Kiefer; Jennifer A Sees; Pintip Chitphakdithai; Ibrahim A Ahmed; Paolo N Anderlini; Amer M Beitinjaneh; Christopher Bredeson; Jan Cerny; Saurabh Chhabra; Andrew Daly; Miguel Angel Diaz; Nosha Farhadfar; Haydar A Frangoul; Siddhartha Ganguly; Dennis A Gastineau; Usama Gergis; Gregory A Hale; Peiman Hematti; Rammurti T Kamble; Kimberly A Kasow; Hillard M Lazarus; Jane L Liesveld; Hemant S Murthy; Maxim Norkin; Richard F Olsson; Mona Papari; Bipin N Savani; Jeffrey Szer; Edmund K Waller; Baldeep Wirk; Jean A Yared; Michael A Pulsipher; Nirali N Shah; Galen E Switzer; Paul V O'Donnell; Dennis L Confer; Bronwen E Shaw
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-02       Impact factor: 5.742

5.  Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation.

Authors:  I G Winkler; A R Pettit; L J Raggatt; R N Jacobsen; C E Forristal; V Barbier; B Nowlan; A Cisterne; L J Bendall; N A Sims; J-P Lévesque
Journal:  Leukemia       Date:  2012-01-23       Impact factor: 11.528

6.  Factors affecting the CD34+ cell yields from the second donations of healthy donors: The steady-state lymphocyte count is a good predictive factor.

Authors:  Zhi-Ping Guo; Tao Wang; Lan-Ping Xu; Xiao-Hui Zhang; Yu Wang; Xiao-Jun Huang; Ying-Jun Chang
Journal:  Transfus Apher Sci       Date:  2016-08-26       Impact factor: 1.764

7.  The replication rate of human hematopoietic stem cells in vivo.

Authors:  Sandra N Catlin; Lambert Busque; Rosemary E Gale; Peter Guttorp; Janis L Abkowitz
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

8.  Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.

Authors:  D F Stroncek; M E Clay; M L Petzoldt; J Smith; W Jaszcz; F B Oldham; J McCullough
Journal:  Transfusion       Date:  1996-07       Impact factor: 3.157

9.  Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields.

Authors:  Javier De la Rubia; Cristina Arbona; Consuelo Del Cañizo; Rosario Arrieta; Felipe De Arriba; María J Pascual; Isabel Sanjuan; Miguel A Díaz; Salut Brunet; Adrián Alegre; Andrés Insunza; Ildefonso Espigado; Concha Zamora; Javier De la Serna; David Serrano; Joan Bargay; José Petit; Dobleta Martínez; Amparo Verdeguer; José M Ribera; Carmen Martínez; Luis Benlloch; Miguel A Sanz
Journal:  J Hematother Stem Cell Res       Date:  2002-08

10.  Remobilization of hematopoietic stem cells in healthy donors for allogeneic transplantation.

Authors:  Mark A Fiala; Soo Park; Michael Slade; John F DiPersio; Keith E Stockerl-Goldstein
Journal:  Transfusion       Date:  2016-06-17       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.